SDC1 and carcinoma: While we cannot make definitive statements about CD138 immunostaining in other mouse cancers, its presence in several human cancers (carcinomas and sarcomas) [18, 19] could suggest CD138 expression in cancers could confound mouse plasmacyte detection and localization.